Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Alexander Amone"'
Autor:
Alexander Amone, Grace Gabagaya, Priscilla Wavamunno, Gordon Rukundo, Joyce Namale-Matovu, Samuel S Malamba, Irene Lubega, Jaco Homsy, Rachel King, Clemensia Nakabiito, Zikulah Namukwaya, Mary Glenn Fowler, Philippa Musoke
Publikováno v:
PLoS ONE, Vol 19, Iss 4, p e0297652 (2024)
IntroductionDespite the scale-up of Option B+, long-term retention of women in HIV care during pregnancy and the postpartum period remains an important challenge. We compared adherence to clinic appointments and antiretroviral therapy (ART) at 6 week
Externí odkaz:
https://doaj.org/article/c4b7725fe776484b9b689fdff1458e58
Autor:
Joseph Rujumba, Rachel L King, Joyce Namale-Matovu, Priscilla Wavamunno, Alexander Amone, Grace Gabagaya, Gordon Rukundo, Mary Glenn Fowler, Jaco Homsy, Janet Seeley, Philippa Musoke
Publikováno v:
PLOS Global Public Health, Vol 3, Iss 11, p e0001326 (2023)
The Friends for Life Circles (FLC) was a parallel randomized controlled trial testing the efficacy of a group peer support intervention to support long-term adherence to Option B+ in Kampala and Mityana districts in Uganda. We explored FLC participan
Externí odkaz:
https://doaj.org/article/0ef54ffa575a4c92b3c14e83aa6d97af
Autor:
Grace Gabagaya, Gordon Rukundo, Alexander Amone, Priscilla Wavamunno, Joyce Namale-Matovu, Irene Lubega, Clemensia Nakabiito, Zikulah Namukwaya, Monica Nolan, Samuel S. Malamba, Rachel King, Jaco Homsy, Mary Glenn Fowler, Philippa Musoke
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-7 (2021)
Abstract Background Viral load (VL) testing is key in monitoring adherence to antiretroviral therapy (ART) and documenting HIV treatment response. As per HIV treatment guidelines in Uganda, the first VL test is recommended 6 months after initiation o
Externí odkaz:
https://doaj.org/article/a6e60a87db6b4a80a90a07879223d0fd
Autor:
Femke Bannink Mbazzi, Zikulah Namukwaya, Alexander Amone, Francis Ojok, Juliane Etima, Josaphat Byamugisha, Elly Katabira, Mary Glenn Fowler, Jaco Homsy, Rachel King, the PRIMAL Study Team
Publikováno v:
BMC Public Health, Vol 20, Iss 1, Pp 1-15 (2020)
Abstract Background The ‘Primary HIV Prevention among Pregnant and Lactating Ugandan Women’ (PRIMAL) randomized controlled trial aimed to assess an enhanced counseling strategy linked to extended postpartum repeat HIV testing and enhanced counsel
Externí odkaz:
https://doaj.org/article/6fe2deb446d14c838237c0db08bb3916
Autor:
Kirsty Le Doare, Philippa Musoke, Annettee Nakimuli, Asma Khalil, Jessica Florence Burt, Joseph Ouma, Lawrence Lubyayi, Alexander Amone, Lorna Aol, Eve Nakabembe, Robert Mboizi, Mary Kyohere, Emily Namara Lugolobi
Publikováno v:
BMJ Global Health, Vol 6, Iss 8 (2021)
Externí odkaz:
https://doaj.org/article/32fe2c3088ea410fb7e21206a206ff23
Autor:
Joseph Rujumba, Jaco Homsy, Femke Bannink Mbazzi, Zikulah Namukwaya, Alexander Amone, Gordon Rukundo, Elly Katabira, Josaphat Byamugisha, Mary Glenn Fowler, Rachel L King
Publikováno v:
PLoS ONE, Vol 16, Iss 6, p e0253616 (2021)
BackgroundHIV status awareness is critical for HIV prevention and care but HIV testing rates remain low in Uganda, especially among men. One suggested approach to increase access and utilisation of HIV testing services is HIV self-testing. We explore
Externí odkaz:
https://doaj.org/article/1279d3e981ba49398f729179db10372e
Autor:
Jaco Homsy, Rachel King, Femke Bannink, Zikulah Namukwaya, Eric Vittinghof, Alexander Amone, Francis Ojok, Gordon Rukundo, Sharon Amama, Juliane Etima, Joyce Matovu, Fitti Weissglas, Lawrence Ojom, Pamela Atim, Lynae Darbes, Josaphat Byamugisha, George Rutherford, Elly Katabira, Mary Glenn Fowler, PRIMAL Study Team
Publikováno v:
PLoS ONE, Vol 14, Iss 2, p e0212119 (2019)
BackgroundThe 'Primary HIV Prevention among Pregnant and Lactating Ugandan Women' (PRIMAL) study aimed to assess the effectiveness of an enhanced HIV counseling intervention for preventing HIV acquisition among HIV-uninfected mothers during pregnancy
Externí odkaz:
https://doaj.org/article/2ac7f2c0ff9d483083250f1d4dbd0032
Autor:
Alexander Amone, Grace Gabagaya, Priscilla Wavamunno, Gordon Rukundo, Joyce Namale-Matovu, Samuel S. Malamba, Irene Lubega, Jaco Homsy, Rachel King, Clemensia Nakabiito, Zikulah Namukwaya, Mary Glenn Fowler, Philippa Musoke
Publikováno v:
medRxiv
Introduction:Despite scale up of Option B+, long-term retention of women in HIV care during pregnancy and the postpartum period remains an important challenge. We compared adherence to clinic appointments and antiretroviral therapy (ART) at different
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f616905c6388cb0d1c8a5861acd59f4
https://doi.org/10.1101/2023.04.15.23288495
https://doi.org/10.1101/2023.04.15.23288495
Autor:
Alexander Amone, Priscilla Wavamunno, Grace Gabagaya, Gordon Rukundo, Joyce Namale-Matovu, Samuel S Malamba, Irene Lubega, Jaco Homsy, Rachel King, Clemensia Nakabiito, Monica Nolan, Mary Glenn Fowler, Philippa Musoke
Publikováno v:
African health sciences, vol 22, iss 4
African Health Sciences; Vol. 22 No. 4 (2022); 428-434
African Health Sciences; Vol. 22 No. 4 (2022); 428-434
Background: Pre-treatment HIV drug resistance is a threat to elimination of mother to child HIV transmission and could lead to virological failure among HIV-positive pregnant women. We analysed genotypic HIV drug resistance (HIVDR) of baseline sample
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f3b7c4a87ca4906a3df5540a8782bf1
https://escholarship.org/uc/item/0382x0nr
https://escholarship.org/uc/item/0382x0nr
Autor:
Rachel King, Gordon Rukundo, Joyce Namale-Matovu, Zikulah Namukwaya, Priscilla Wavamunno, Alexander Amone, Monica Nolan, Clemensia Nakabiito, Samuel S. Malamba, Irene Lubega, Jaco Homsy, Philippa Musoke, Mary Glenn Fowler, Grace Gabagaya
Publikováno v:
BMC infectious diseases, vol 21, iss 1
BMC Infectious Diseases
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-7 (2021)
BMC Infectious Diseases
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-7 (2021)
Background Viral load (VL) testing is key in monitoring adherence to antiretroviral therapy (ART) and documenting HIV treatment response. As per HIV treatment guidelines in Uganda, the first VL test is recommended 6 months after initiation of ART. Un